TELA Bio, Inc. (TELA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.84M | -3.5% |
| 2024 | $52.67M | +12.7% |
| 2023 | $46.73M | +11.2% |
| 2022 | $42.02M | -4.4% |
| 2021 | $43.93M | -40.9% |
| 2020 | $74.39M | +64.2% |
| 2019 | $45.30M | +162.2% |
| 2018 | $17.28M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.84M | -3.5% |
| 2024 | $52.67M | +12.7% |
| 2023 | $46.73M | +11.2% |
| 2022 | $42.02M | -4.4% |
| 2021 | $43.93M | -40.9% |
| 2020 | $74.39M | +64.2% |
| 2019 | $45.30M | +162.2% |
| 2018 | $17.28M | — |